Clinical trials: Radioligand

Prostate Cancer (Adenocarcinoma), Prostate Biopsy

RegisterPROS - A Registry for Prostate Cancers

• Enrolling by invitation
• Age: 45 to 100 years
• Observational study
• Medical device

Prostate cancers are derived from epithelial cells in the prostate gland. Treatment options include surgery, medical (androgen signaling targeted and chemotherapy) and radiation therapy including radioligand therapy (RLT).

Conditions

Prostate Cancer (Adenocarcinoma), Prostate Biopsy, Prostatectomy, Radioligand

Trial name

RegisterPROS (NCT06872619)

Testing

PROSTest

Where

Germany

Volunteers

1,000 people, healthy volunteers welcome

Sponsor

Wren Laboratories LLC